Vernakalant hydrochloride for rapid conversion of atrial fibrillation: a phase 3, randomized, placebo-controlled trial.
Roy D, Pratt CM, Torp-Pedersen C, Wyse DG, Toft E, Juul-Moller S, Nielsen T, Rasmussen SL, Stiell IG, Coutu B, Ip JH, Pritchett EL, Camm AJ; Atrial Arrhythmia Conversion Trial Investigators.
Circulation. 2008 Mar 25;117(12):1518-25. Epub 2008 Mar 10.PMID: 18332267 [PubMed - indexed for MEDLINE]Related articlesFree article